{"id":7838,"date":"2026-05-28T06:20:00","date_gmt":"2026-05-28T06:20:00","guid":{"rendered":"https:\/\/realheart.se\/mfn_news\/realheart-granted-patent-approval-in-china\/"},"modified":"2026-05-28T06:20:00","modified_gmt":"2026-05-28T06:20:00","slug":"realheart-granted-patent-approval-in-china","status":"publish","type":"mfn_news","link":"https:\/\/realheart.se\/sv\/mfn_news\/realheart-granted-patent-approval-in-china\/","title":{"rendered":"Realheart Granted Patent Approval in China"},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p><strong>V\u00e4ster\u00e5s, Sweden, June 28, 2026 \u2013 Scandinavian Real Heart AB (publ) announces today that the company has been granted a patent approval in China. The patent covers a control method and system configuration for artificial heart products, such as Realheart\u00ae TAH, featuring integrated feedback mechanisms for real-time regulation of cardiac output. The approval grants patent protection in China until March 2041.<\/strong><\/p>\n<\/div>\n<div class=\"mfn-body\">\n<p>Realheart is developing Realheart\u00ae TAH, the first total artificial heart that mimics the structure and function of the native human heart. The patent (ZL2021800364627) covers a control method and system configuration for an artificial heart, featuring integrated feedback mechanisms for real-time regulation of cardiac output. In detail, the system is designed to ensure precise and safe control of pump performance in medical environments.<\/p>\n<p>The method supports continuous monitoring and adaptive adjustment of key parameters, including pressure, flow, and pump speed, enabling automated control of artificial hearts and circulatory support systems such as Realheart\u00ae TAH. This is intended to support hemodynamic stability, with the potential to contribute to improved treatment outcomes. The method and associated configuration are designed for integration into Realheart\u2019s existing and future pump devices, and are also compatible with third-party total artificial heart and circulatory support systems.<\/p>\n<p>Region: Mainland China<br \/>Patent number: ZL 2021800364627<br \/>Expiration date: March 2041<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-contacts mfn-ddde9c982a0b\">\n<p><strong class=\"mfn-heading-1\">For more information, please contact:<\/strong><br \/>Ina Laura Perkins, CEO<br \/>Phone: +46 (0) 70 406 49 21\u00a0<br \/>E-mail: <a href=\"mailto:inalaura.perkins@realheart.se\" rel=\"noopener\" target=\"_blank\">inalaura.perkins@realheart.se<\/a><br \/>Certified Adviser: Svensk Kapitalmarknadsgranskning AB, <a href=\"http:\/\/www.skmg.se\" rel=\"noopener\" target=\"_blank\">www.skmg.se<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about mfn-0285b54ad9f5\">\n<p><strong class=\"mfn-heading-1\">About Us<\/strong><br \/>Scandinavian Real Heart AB (publ) is developing the first artificial heart that mimics the shape, function, and blood flow pattern of the human heart. These unique product features provide completely new opportunities to save lives and give patients a good quality of life while waiting for a heart transplant. In the future, artificial hearts may also become an alternative to transplantation for broader groups of patients with severe heart failure. Realheart\u00ae TAH (Total Artificial Heart) is now being evaluated in extensive preclinical trials ahead of a first clinical study in patients. The company&#039;s shares are traded on Nasdaq Stockholm First North Growth Market. For more information, visit <a href=\"http:\/\/www.realheart.se\" rel=\"noopener\" target=\"_blank\">www.realheart.se<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<p><strong class=\"mfn-heading-1\">Attachments<\/strong><br \/><a class=\"mfn-generated mfn-primary\" href=\"https:\/\/storage.mfn.se\/9756d13e-1c36-4db6-9486-70eb009d0876\/realheart-granted-patent-approval-in-china.pdf\" rel=\"noopener\" target=\"_blank\">Realheart Granted Patent Approval in China<\/a><\/p>\n<\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><div class=\"mfn-attachment\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/9756d13e-1c36-4db6-9486-70eb009d0876\/realheart-granted-patent-approval-in-china.pdf\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/9756d13e-1c36-4db6-9486-70eb009d0876\/realheart-granted-patent-approval-in-china.pdf?type=jpg\"><\/span>Realheart Granted Patent Approval in China<\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>V\u00e4ster\u00e5s, Sweden, June 28, 2026 \u2013 Scandinavian Real Heart AB (publ) announces today that the company has been granted a patent approval in China. The patent covers a control method and system configuration for artificial heart products, such as Realheart\u00ae TAH, featuring integrated feedback mechanisms for real-time regulation of cardiac output. The approval grants patent&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-7838","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-ext-nq","mfn-news-tag-mfn-ext-nq-company-announcement","mfn-news-tag-mfn","mfn-news-tag-mfn-ci-other"],"acf":[],"aioseo_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Realheart Granted Patent Approval in China - Realheart<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/realheart.se\/mfn_news\/realheart-granted-patent-approval-in-china\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Realheart Granted Patent Approval in China - Realheart\" \/>\n<meta property=\"og:description\" content=\"V\u00e4ster\u00e5s, Sweden, June 28, 2026 \u2013 Scandinavian Real Heart AB (publ) announces today that the company has been granted a patent approval in China. The patent covers a control method and system configuration for artificial heart products, such as Realheart\u00ae TAH, featuring integrated feedback mechanisms for real-time regulation of cardiac output. The approval grants patent...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/realheart.se\/mfn_news\/realheart-granted-patent-approval-in-china\/\" \/>\n<meta property=\"og:site_name\" content=\"Realheart\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-granted-patent-approval-in-china\\\/\",\"url\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-granted-patent-approval-in-china\\\/\",\"name\":\"Realheart Granted Patent Approval in China - Realheart\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\"},\"datePublished\":\"2026-05-28T06:20:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-granted-patent-approval-in-china\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-granted-patent-approval-in-china\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-granted-patent-approval-in-china\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Realheart Granted Patent Approval in China\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\",\"url\":\"https:\\\/\\\/realheart.se\\\/\",\"name\":\"Realheart\",\"description\":\"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/realheart.se\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Realheart Granted Patent Approval in China - Realheart","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/realheart.se\/mfn_news\/realheart-granted-patent-approval-in-china\/","og_locale":"sv_SE","og_type":"article","og_title":"Realheart Granted Patent Approval in China - Realheart","og_description":"V\u00e4ster\u00e5s, Sweden, June 28, 2026 \u2013 Scandinavian Real Heart AB (publ) announces today that the company has been granted a patent approval in China. The patent covers a control method and system configuration for artificial heart products, such as Realheart\u00ae TAH, featuring integrated feedback mechanisms for real-time regulation of cardiac output. The approval grants patent...","og_url":"https:\/\/realheart.se\/mfn_news\/realheart-granted-patent-approval-in-china\/","og_site_name":"Realheart","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/realheart.se\/mfn_news\/realheart-granted-patent-approval-in-china\/","url":"https:\/\/realheart.se\/mfn_news\/realheart-granted-patent-approval-in-china\/","name":"Realheart Granted Patent Approval in China - Realheart","isPartOf":{"@id":"https:\/\/realheart.se\/#website"},"datePublished":"2026-05-28T06:20:00+00:00","breadcrumb":{"@id":"https:\/\/realheart.se\/mfn_news\/realheart-granted-patent-approval-in-china\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/realheart.se\/mfn_news\/realheart-granted-patent-approval-in-china\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/realheart.se\/mfn_news\/realheart-granted-patent-approval-in-china\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"MFN News Items","item":"https:\/\/realheart.se\/mfn_news\/"},{"@type":"ListItem","position":2,"name":"Realheart Granted Patent Approval in China"}]},{"@type":"WebSite","@id":"https:\/\/realheart.se\/#website","url":"https:\/\/realheart.se\/","name":"Realheart","description":"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/realheart.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news\/7838","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/media?parent=7838"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}